RI H7042 | 2018 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on January 3 2018 - 25% progression, died in committee
Action: 2018-02-13 - Committee recommended measure be held for further study
Pending: House Corporations Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Directs the state board of pharmacy to annually develop a list of critical prescription drugs for which there is a substantial public interest in understanding the development of the drugs’ price.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Pharmacies

Sponsors


History

DateChamberAction
2018-02-13HouseCommittee recommended measure be held for further study
2018-02-09HouseScheduled for hearing and/or consideration (02/13/2018)
2018-01-29HouseCommittee transferred to House Corporations
2018-01-03HouseIntroduced, referred to House H.E.W.

Subjects


Rhode Island State Sources


Bill Comments

feedback